Motion sickness may occur during travel by sea, automobile, airplane, and space. Susceptibility changes with age and may be influenced by psychological factors. Susceptibility can be reduced in most people by medications that involve histamine or neurotransmitters acetylcholine and noradrenaline, and influence the vestibular system.
Get full access to this article
View all access options for this article.
References
1.
FrankJ., & LevensonH. N. (1976–1977) Seasickness mechanisms and medications in dysmetric dyslexia and dyspraxia. Academic Therapy, 12, 133–153.
2.
FrankJ., & LevensonH. N. (1977) Anti-motion medications in dysmetric dyslexia and dyspraxia. Academic Therapy, 12, 411–424.
3.
GordonC.BinahO.AttiasJ., & KolnickA. (1986) Transdermal scopolamine: performance with side effects. Aviation, Space, & Environmental Medicine, 57, 236–240.
4.
KohlR. L. (1983) Sensory conflict theory of space motion sickness: an anatomical location for the neuroconflict. Aviation, Space, & Environmental Medicine, 54, 464–465.
5.
KohlR. L. (1987) Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviation, Space, & Environmental Medicine, 58, 125–131.
6.
KohlR. L.CalkinsD. S., & MandellA. J. (1986) Arousal and stability: the effects of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness. Aviation, Space, & Environmental Medicine, 57, 137–143.
7.
KohlR., & HomickJ. L. (1983) Motion sickness: a modulatory role for the central cholinergic nervous system. Neuroscience and Biobehavioral Reviews, 7, 73–85.
8.
LawtherA. J., & GriffinM. J. (1988) A survey of the occurrence of motion sickness amongst passengers at sea. Aviation, Space, and Environmental Medicine, 59, 399–406.
9.
LeeJ. A.WatsonL. A., & BoothbyG. (1986) Calcium antagonists in the prevention of motion sickness. Aviation, Space, & Environmental Medicine, 57, 45–48.
10.
OosterveldW. J. (1987) The combined effect of cinnarizine and domperidone on vestibular susceptibility. Aviation, Space, & Environmental Medicine, 58, 218–223.
11.
ParkerD. M. (1971) A psychophysiological test for motion-sickness susceptibility. Journal of General Psychology, 85, 87–92.
12.
ParkerD. M.SchafferJ., & CohenE. (1972) The effect of past experience on motion sickness produced by visual stimuli. Journal of General Psychology, 87, 65–68.
13.
Physicians Desk Reference. (1996) Medical Economics Co., Montvale, NJ.
14.
PinderR. M.BrogdenR. N.SawyerP. R.SpeightT. M., & AveryG. S. (1976) Metoclopramide: a review of its pharmacological properties and clinical use. Drugs, 12, 81–131.
15.
SchmedtjeJ. F.Jr.OmanC. M.LetzR., & BakerE. L. (1988) Effects of scopolamine and dextroamphetamine on human performance. Aviation, Space, & Environmental Medicine, 59, 407–410.
16.
SchroederD. J.CollinsW. E., & ElamG. W. (1985) Effects of some motion sickness suppressants on static and dynamic tracking performance. Aviation, Space, & Environmental Medicine, 56, 344–350.
17.
WoodC. D. (1979) Antimotion sickness and antiemetic drugs. Drugs, 17, 471–479.
18.
WoodC. D.MannoJ. E.MannoB. R.OdenheimerR. C., & BairnsfatherL. E. (1986) The effect of antimotion sickness drugs on habituation to motion. Aviation, Space, & Environmental Medicine, 57, 539–542.
19.
WoodC. D.MannoJ. E.MannoB. R.RedetzkiH. M.WoodM. J., & MimsM. F. (1985) Evaluation of antimotion sickness drug side effects on performance. Aviation, Space, & Environmental Medicine, 56, 310–316.
